Top 10 Challenges in Cancer Immunotherapy

Challenges to Prostate Cancer Immunotherapy

Immunotherapy of Cancer

This article has no abstract.

Challenges in Immune Profiling of Cancer Immunotherapy

Submit Manuscript | http://medcraveonline.com Abbreviations: PBMC: Peripheral Blood Mononuclear Cells; TME: Tumor Microenvironment; FFPE: Formalin-Fixed ParaffinEmbedded; OCT: Optimal Cutting Media; RNA: Ribonucleic Acid; DNA: Deoxy Ribonucleic Acid; TCR: T Cell Receptor; TIL: Tumor Infiltrating Lymphocytes; IHC: Immunohistochemistry; Cytof: For Cytometry by Time of Flight; Elispo: Enzyme Linke...

Emerging Opportunities and Challenges in Cancer Immunotherapy.

Immunotherapy strategies against cancer are emerging as powerful weapons for treatment of this disease. The success of checkpoint inhibitors against metastatic melanoma and adoptive T-cell therapy with chimeric antigen receptor T cells against B-cell-derived leukemias and lymphomas are only two examples of developments that are changing the paradigms of clinical cancer management. These changes...

New approaches in cancer immunotherapy: review article

Cancer immunotherapy refers to any intervention that leverages the immune system to eliminate a malignancy. Successful cancer immunotherapies generate an anti-cancer response that is systemic, specific, and durable and overcome to the primary limitations of traditional cancer treatment modalities. In this review paper, the effective methods in immune system to treat cancer, such as immunosuppre...